Showing 7871-7880 of 10401 results for "".
- AbbVie Launches “Let Me Be Clear” to Urge Psoriasis Patients to Speak Uphttps://practicaldermatology.com/news/abbvie-launches-let-me-be-clear-to-urge-psoriasis-patients-to-speak-up/2460202/AbbVie is launching Let Me Be
- Meet Ortho Derm’s 2019 Aspire Higher Scholarship Winnershttps://practicaldermatology.com/news/meet-ortho-derms-2019-aspire-higher-scholarship-winners/2460177/Ortho Dermatologics
- Melanoma Breakthrough: Researchers Discover Why Some Patients Respond to Immunotherapyhttps://practicaldermatology.com/news/melanoma-breakthrough-researchers-discover-why-some-patients-respond-to-immunotherapy-yet-others-dont/2460143/Israeli researchers now know why 60 percent of patients with metastatic melanoma do not respond to immunotherapy. After examining tumors of 116 patients using proteomics, the researchers found the non-responding patients tended to have lower fatty acid metabolism, meaning that their enz
- Duobrii Lotion for Plaque Psoriasis Hits Shelveshttps://practicaldermatology.com/news/duobrii-lotion-for-plaque-psoriasis-hits-shelves/2460079/Ortho Dermatologics’ Duobrii (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%, is now available. Approved by the U.S. Food and Drug Administration on April 25, 2019, Duobrii is the first and only topical lotion that contains a uniq
- Crown Laboratories Adds to Portfoliohttps://practicaldermatology.com/news/crown-laboratories-adds-to-portfolio/2460040/On the heels of a brand relaunch this week,Crown Laboratories’ Aesthetics division, Bellus Medical, has acquired the HD PRP system for the aesthetic marketplace from Healeon Medical, Inc. The system is designed to meet the demands of busy practices seeking higher volume and higher yiel
- MoleSafe USA Launches Interactive Challenge for Skin Cancer Awareness Monthhttps://practicaldermatology.com/news/molesafe-usa-launches-interactive-challenge-for-skin-cancer-awareness-month/2460019/MoleSafe USA, LLC is launching an interactive, online
- InMode Launches AccuTite, the Smallest RFAL Treatment for Face and Bodyhttps://practicaldermatology.com/news/inmode-launches-accutite-the-smallest-rfal-treatment-for-face-and-body/2460000/InMode Ltd
- A Conserved Stress Response May Fuel Resistance to BRAF Inhibitors in Melanomahttps://practicaldermatology.com/news/a-conserved-stress-response-may-fuel-resistance-to-braf-inhibitors-in-melanoma/2459999/Moffitt Cancer
- PellePharm: Phase 3 Trials for Patidegib for Gorlin Syndrome Underwayhttps://practicaldermatology.com/news/pellepharm-phase-3-trials-for-patidegib-for-gorlin-syndrome-underway-1/2459990/
- Candela Unveils New Corporate Identity at the 2019 AAD Annual Meetinghttps://practicaldermatology.com/news/candela-unveils-new-corporate-identity-at-the-2019-aad-annual-meeting/2459874/Syneron-Candela has rebranded the company to Candela and unveiled its new corporate branding at the American Academy of Dermatology (AAD) Annual Meeting. The new corporate identity reflects the unification of the Syneron and Candela brands and is designed to support continued global market growth